HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

54.300

+4.0007.95%

Volume:10.77M

Turnover:571.61M

Market Cap:31.66B

PE:-12.12

High:54.950

Open:49.680

Low:49.320

Close:50.300

52wk High:80.900

52wk Low:29.980

Shares:583.00M

HK Float Shares:583.00M

Volume Ratio:1.53

T/O Rate:1.85%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-1.36%

PB:7.38

PE(LYR):-12.12

PS:29.87

Loading ...

Overview Company News Filings

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven Nlrp3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration With Hygtia Therapeutics

THOMSON REUTERS

InSilico Medicine Completes First Human Dosing of Parkinson's Disease Drug in Phase 1 Trial

MT Newswires Live

INSILICO Shares Surge Over 6% in Morning Session Following First Patient Dosing Milestone for NLRP3 Inhibitor

Movement Alert｜Insilico Medicine Rises 5.17% in Regular Trading, ISM8969 Achieves First Clinical Milestone with First-in-Human Dosing

Key Hong Kong Market Announcements: Six Firms Launch IPOs, Yum China to Acquire Pizza Hut China for US$1.2 Billion

INSILICO and Hengtai Biotech Achieve First Clinical Milestone for Jointly Developed ISM8969, Dosing Initial Patient in Phase I Study

Insilico Medicine completes first patient dosing in Phase 1 trial of NLRP3 inhibitor ISM8969

Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound

BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series

Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment

INSILICO Added to Key China Securities Index Series

Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness

Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price

Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness

Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness

Insilico Medicine to Join FTSE Global Equity Index Series

MT Newswires Live

INSILICO to be Added to FTSE Global Equity Index Series

Movement Alert｜Insilico Medicine Rises 5.37% in Regular Trading, Technical Rebound After Nearly 40% Monthly Decline Amid Sector Strength

INSILICO Maintains Stable Share Capital Structure in May 2026 Monthly Return

Bulletin Express

Movement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/03696/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":54.3,"timestamp":1789621809616,"preClose":50.3,"halted":0,"volume":10767018,"delay":0,"changeRate":0.07952286282306163,"floatShares":583000000,"shares":583000000,"eps":-4.48,"marketStatus":"Trading","change":4,"latestTime":"09-17 13:10:20","open":49.68,"high":54.95,"low":49.32,"amount":571608766,"amplitude":0.111928,"askPrice":54.4,"askSize":2000,"bidPrice":54.3,"bidSize":28000,"shortable":3,"etf":0,"ttmEps":-4.006,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789632600000},"marketStatusCode":2,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":50.3,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"volumeRatio":1.525382,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":583000000,"roa":"-1.36%","roe":"--","lyrEps":-4.48,"volumeRatio":1.525382,"shares":583000000,"dividePrice":0,"high":54.95,"amplitude":0.111928,"preClose":50.3,"low":49.32,"week52Low":29.98,"pbRate":"7.38","psRate":"29.87","week52High":80.9,"institutionHeld":0,"latestPrice":54.3,"committee":0.866667,"eps":-4.48,"divideRate":0,"volume":10767018,"delay":0,"ttmEps":-4.006,"open":49.68,"prevYearClose":37.14,"prevWeekClose":50.5,"prevMonthClose":43.74,"prevQuarterClose":39.62,"fiveDayClose":53.9,"twentyDayClose":44.2,"sixtyDayClose":42.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-09-15","current":-12.556166,"percent":0.511494,"low":-126.474328,"twenty":-92.430472,"median":-12.517861,"eighty":-8.860169,"high":-6.819055,"avg":-39.838524,"sd":41.280795,"marketCap":29166193788},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240},{"date":"2026-08-28","current":-11.42993,"twenty":-93.240519,"median":-12.603589,"eighty":-8.725669,"marketCap":26661298566},{"date":"2026-09-04","current":-12.035257,"twenty":-93.142096,"median":-12.516782,"eighty":-8.763781,"marketCap":28077860002},{"date":"2026-09-11","current":-12.463145,"twenty":-92.779015,"median":-12.517861,"eighty":-8.825762,"marketCap":29079818091},{"date":"2026-09-15","current":-12.494938,"twenty":-92.430472,"median":-12.517861,"eighty":-8.860169,"marketCap":29166193788}],"updateTime":1789579318278},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644749844","title":"Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven Nlrp3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration With Hygtia Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749844","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749844?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA7DC6R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644413718","title":"InSilico Medicine Completes First Human Dosing of Parkinson's Disease Drug in Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644413718","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644413718?lang=en_us&edition=fundamental","pubTime":"2026-06-17 13:52","pubTimestamp":1781675530,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman  completed first-in-human dosing in a phase 1 clinical trial of ISM8969, according to a Wednesday Hong Kong bourse filing.The oral NLRP3 inhibitor is being developed to treat chronic neuroinflammation and central nervous system disorders, including Parkinson's disease.The milestone marks the first clinical achievement under the company's co-development collaboration with Hygtia Therapeutics.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199395994","title":"INSILICO Shares Surge Over 6% in Morning Session Following First Patient Dosing Milestone for NLRP3 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1199395994","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199395994?lang=en_us&edition=fundamental","pubTime":"2026-06-17 10:14","pubTimestamp":1781662465,"startTime":"0","endTime":"0","summary":"Shares of INSILCO (03696) rose more than 6% during the morning trading session. At the time of writing, the stock was up 4.93% to HK$34.5, with a turnover of HK$21.1158 million. Key Development The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","03696","BK4585","BK1141","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103060181","title":"Movement Alert｜Insilico Medicine Rises 5.17% in Regular Trading, ISM8969 Achieves First Clinical Milestone with First-in-Human Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=1103060181","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103060181?lang=en_us&edition=fundamental","pubTime":"2026-06-17 09:58","pubTimestamp":1781661503,"startTime":"0","endTime":"0","summary":"On June 17, Insilico Medicine rose 5.17% in regular trading, trading at 34.62 HKD/share, with turnover of approximately 13.92 million HKD.On the news front, the company announced that ISM8969,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150986317","title":"Key Hong Kong Market Announcements: Six Firms Launch IPOs, Yum China to Acquire Pizza Hut China for US$1.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1150986317","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150986317?lang=en_us&edition=fundamental","pubTime":"2026-06-17 09:26","pubTimestamp":1781659607,"startTime":"0","endTime":"0","summary":"Several new listings are commencing their public offerings in Hong Kong. Lingyi Itech(Guangdong)Company (HKEX: 01688) has initiated its share offering today, with cornerstone investors including GF...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YUMC","BK0028","LU0128522157.USD","LU0823426480.USD","02252","LU2177674079.SGD","03696","BK4588","BK1100","BK0081","LU0320764755.SGD","LU0823426308.USD","BK1617","BK4526","02889","IE0003895053.USD","LU0650527681.SGD","LU0708994859.HKD","BK0132","06675","LU0672654166.SGD","LU2008162690.USD","BK4531","HK0000320223.HKD","BK1141","BK4209","IE0034224299.USD","LU0228659784.USD","BK1588","LU0456842615.SGD","HK0000306685.HKD","IE00BGV7N243.SGD","BK0214","LU0128525929.USD","LU0868486357.SGD","LU1051768304.USD","LU0327786744.USD","LU0348825331.USD","LU0359202008.SGD","002600","LU1515016050.SGD","VXUS","BK0077","BK4504","HK0000320264.USD","LU0359201612.USD","LU0572944931.SGD","BK1233","LU2279701549.SGD","BK4585","LU0310800379.SGD","LU0029864427.USD","BK0084","688630","LU0417516902.SGD","IPOS","LU0543330483.HKD","LU1023057109.AUD","BK0251","BK1144","LU0029875118.USD","LU0431992006.USD","LU0594300419.USD","LU1267930573.SGD","LU0651946864.USD","IE00B0JY6N72.USD","HK0000306701.USD","09987"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145575282","title":"INSILICO and Hengtai Biotech Achieve First Clinical Milestone for Jointly Developed ISM8969, Dosing Initial Patient in Phase I Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1145575282","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145575282?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:36","pubTimestamp":1781656586,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that ISM8969, co-developed with Shenzhen Hengtai Biotechnology Co., Ltd. (Hengtai Biotech), has reached its first clinical milestone with the administration of the first...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644679699","title":"Insilico Medicine completes first patient dosing in Phase 1 trial of NLRP3 inhibitor ISM8969","url":"https://stock-news.laohu8.com/highlight/detail?id=2644679699","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644679699?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:00","pubTimestamp":1781654440,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman Topco dosed the first participant in a Phase 1 study of ISM8969, an oral NLRP3 inhibitor developed with HengTai Bio.No clinical results have been presented; the announcement covers trial initiation and first-in-human dosing.The study is designed to assess safety and tolerability in healthy volunteers and obese adults with cardiovascular risk.Insilico granted HengTai Bio global rights to develop and commercialize ISM8969; the partners split worldwide economics 50%-50%.The deal includes up to USD 66 million in upfront and milestone payments to Insilico.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL76jGx7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199143421","title":"Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143421","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199143421?lang=en_us&edition=fundamental","pubTime":"2026-06-16 10:08","pubTimestamp":1781575721,"startTime":"0","endTime":"0","summary":"On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643226457","title":"BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2643226457","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643226457?lang=en_us&edition=fundamental","pubTime":"2026-06-15 10:07","pubTimestamp":1781489229,"startTime":"0","endTime":"0","summary":"BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series** Shares of InSilico Medicine Cayman TopCo 3696.HK jump  7.6% to HK$36.4, on course for biggest one-day pct gain since May 22** Stock of the AI-driven drug discovery and pipeline development group hits the highest level since June 9  ** Co says it has been included in China Securities Index Series, including CSI Hong Kong Connect Innovative Drug Index .CSI931250, CSI Hong Kong Brand Name Drug Index .CSI931787, and CSI HK Connect Health Care Composite Index .CSI930965, effective June 15** Inclusion expected to broaden co's exposure among international institutional investors and research analysts, attract capital inflows from passive funds tracking indexes, diversify shareholder base, and improve trading liquidity for its shares - co** YTD, stock down 5.1%, Hang Seng Biotech Index .HSBIO down 12.5%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL1N42N01K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150477327","title":"Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1150477327","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150477327?lang=en_us&edition=fundamental","pubTime":"2026-06-15 09:46","pubTimestamp":1781487998,"startTime":"0","endTime":"0","summary":"On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.On the news front, the company was formally included in the CSI Index...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178074634","title":"INSILICO Added to Key China Securities Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=1178074634","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178074634?lang=en_us&edition=fundamental","pubTime":"2026-06-15 08:10","pubTimestamp":1781482226,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced its inclusion in several China Securities Index series. The company will be added to the CSI Hong Kong Stock Connect Innovative Drug Index (Code: 931250), the CSI Hong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165934834","title":"Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1165934834","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165934834?lang=en_us&edition=fundamental","pubTime":"2026-06-11 09:58","pubTimestamp":1781143111,"startTime":"0","endTime":"0","summary":"On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185699673","title":"Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1185699673","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185699673?lang=en_us&edition=fundamental","pubTime":"2026-06-10 10:15","pubTimestamp":1781057701,"startTime":"0","endTime":"0","summary":"On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.On the news front, the company's cornerstone investors and employee...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128579425","title":"Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1128579425","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128579425?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:26","pubTimestamp":1780975586,"startTime":"0","endTime":"0","summary":"On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.On the news front, the company's cornerstone investors and employee...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124659105","title":"Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1124659105","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124659105?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:23","pubTimestamp":1780885412,"startTime":"0","endTime":"0","summary":"On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.On the news front, the company's cornerstone investors...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641177397","title":"Insilico Medicine to Join FTSE Global Equity Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2641177397","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641177397?lang=en_us&edition=fundamental","pubTime":"2026-06-08 09:43","pubTimestamp":1780882986,"startTime":"0","endTime":"0","summary":"Insilico Medicine  will be added to the FTSE Global Equity Index Series following FTSE Russell's quarterly review, according to a Monday Hong Kong bourse filing.The artificial intelligence drug discovery company will join the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index, with the changes taking effect on June 22.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","BK4585","EQR","BK4215","BK4588","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171487009","title":"INSILICO to be Added to FTSE Global Equity Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=1171487009","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171487009?lang=en_us&edition=fundamental","pubTime":"2026-06-08 08:22","pubTimestamp":1780878152,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that, following the quarterly review by FTSE Russell, the company will be included in the FTSE Global Equity Index Series. This inclusion encompasses the FTSE Global...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157665917","title":"Movement Alert｜Insilico Medicine Rises 5.37% in Regular Trading, Technical Rebound After Nearly 40% Monthly Decline Amid Sector Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=1157665917","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157665917?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:54","pubTimestamp":1780624499,"startTime":"0","endTime":"0","summary":"On June 5, Insilico Medicine rose 5.37% in regular trading, trading at 38.96 HKD/share, with trading volume of 33.69 million HKD.On the news front, the stock experienced a technical rebound after...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130459573","title":"INSILICO Maintains Stable Share Capital Structure in May 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1130459573","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130459573?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:03","pubTimestamp":1780563831,"startTime":"0","endTime":"0","summary":"On 04 June 2026, InSilico Medicine Cayman TopCo (“INSILICO”) submitted its monthly return to the Hong Kong Stock Exchange, covering the period ended 31 May 2026. The filing shows no changes to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180676220","title":"Movement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1180676220","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180676220?lang=en_us&edition=fundamental","pubTime":"2026-06-04 09:55","pubTimestamp":1780538103,"startTime":"0","endTime":"0","summary":"On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}